Effectiveness of oseltamivir in reducing COVID-19 related in-hospital deaths: a pharmacoepidemiologic study
Description
CONCLUSIONS: Overall, the use of oseltamivir was found to be associated with an attributable risk reduction of 2.50% (95% CI 1.77%-3.29%). Similar results were observed in those who were admitted to the ICU, and on non-invasive and invasive
